Results 261 to 270 of about 112,073 (304)

Non-alcoholic fatty liver disease

Lancet, The, 2021
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of 25% and is a leading cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a disease continuum from steatosis with or without mild inflammation (non-alcoholic fatty liver), to non-alcoholic steatohepatitis (NASH), which is characterised by necroinflammation and faster ...
Elizabeth E Powell   +2 more
exaly   +5 more sources

Non-alcoholic fatty liver disease

Scandinavian Journal of Gastroenterology, 2007
Non-alcoholic fatty liver disease (NAFLD) affects a substantial proportion of the population and has a close association with insulin resistance.
Einar, Björnsson, Paul, Angulo
openaire   +2 more sources

Non‐alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology, 2002
AbstractNon‐alcoholic fatty liver disease (NAFLD) is a chronic liver disease that affects a high proportion of the world’s population. Insulin resistance and oxidative stress play a critical role in the pathogenesis of NAFLD. Clinical, biochemical and imaging studies are of value in the diagnostic evaluation of patients with NAFLD, but liver biopsy ...
Paul, Angulo, Keith D, Lindor
openaire   +2 more sources

Home - About - Disclaimer - Privacy